Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Current study results indicate that HIV/AIDS patients are disproportionately affected by cardiovascular diseases (CVDs) despite effective viral load suppression with antiretroviral therapy (ART). The mechanisms underlying this relationship are complex and incompletely understood, involving a interplay of traditional cardiovascular risk factors, chronic inflammation, and metabolic side effects of ART.

HIV/AIDS Research Yields New Insights into Eradication Strategies

Experts in the field of HIV/AIDS research gathered at the Keystone Symposia conference in Durban, South Africa, to discuss novel strategies for eradicating the virus. The conference, held between April 7-10 2025, brought together experts to share their findings on the persistence of HIV reservoirs and the development of

Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Antiretroviral agents

HIV/AIDS Research Yields New Insights into Eradication Strategies

Antiretroviral agents

HIV/AIDS Management and Prevention: A New Frontier in Cardiovascular Disease Management

Antiretroviral agents

Comparative Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir for COVID-19 Patients with Type 2 Diabetes

Researchers have compared the effectiveness of molnupiravir and nirmatrelvir-ritonavir for non-hospitalized and hospitalized COVID-19 patients with type 2 diabetes (T2DM) using territory-wide electronic health records in Hong Kong. The study, published in the journal Diabetes, Obesity and Metabolism, found that the use of nirmatrelvir-ritonavir may be preferred to molnupiravir for

Antiretroviral agents

Prevalence and Risk Factors of Dermatologic Diseases among People with HIV

A new longitudinal cohort study published in the Journal of the American Academy of Dermatology has investigated the prevalence, incidence, and risk factors of dermatologic diseases among people with human immunodeficiency virus (HIV). The study, conducted in Washington, D.C., analyzed data from 11,738 adults enrolled in the DC

Antiretroviral agents

Prevalence and Risk Factors of Dermatologic Diseases among People with HIV

Antiretroviral agents

New Study Reveals Effective HIV Prevention Strategy for Young Adults in Rural South Africa

A new cluster-randomized stepped-wedge trial in South Africa has shown that community-based peer navigators can effectively mobilize demand for HIV prevention and care among young adults in rural areas. The study, conducted in collaboration with the Africa Health Research Institute, aimed to investigate whether a tailored approach to HIV prevention

Antiretroviral agents

Hypermutated HIV Proviruses Persist in All People Living with HIV on Antiretroviral Therapy

Recent research from Simon Fraser University has shed new light on the persistence of hypermutated proviruses in people living with HIV, despite antiretroviral therapy (ART). The study, published in the journal Virus Evolution, found that hypermutated proviruses, which arise from the action of host antiviral APOBEC3 proteins, are present in

Antiretroviral agents

HIV/AIDS Research Reveals Equivalent Outcomes with Antiretroviral Therapy Switch

A study published in Clinical Infectious Diseases has provided new insights into the effects of antiretroviral therapy (ART) on mid-term systemic inflammation and metabolic health in individuals with HIV-1. According to the research, switching from a widely used ART regimen, dolutegravir/lamivudine (DTG/3TC), to bictegravir/emtricitabine/tenofovir alafenamide (BIC/

HIV

Researchers Develop New Mathematical Model to Study HIV and SARS-CoV-2 Coinfection Dynamics

Researchers at the University of Porto have developed a novel mathematical model to capture the coinfection dynamics of HIV and SARS-CoV-2 under the influence of highly active antiretroviral therapy (HAART). The model takes into account the effect of HAART on both infections and derives the basic reproduction numbers for each

See all